Prelude Capital Management, LLC Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 14, 2019	SELL	$84.4 - $106.53 $236,320 - $298,284	-2,800 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$91.13 - $142.5 $9,113 - $14,250	100 Added 3.7%	2,800 $293,000
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $279,396 - $388,368	2,700 New	2,700 $338,000
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $426,465 - $969,930	-4,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $932,850 - $1.35 Million	4,500 New	4,500 $964,000

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.